Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

9.1%

1 terminated/withdrawn out of 11 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

18%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

Phase 1
3(33.3%)
N/A
3(33.3%)
Phase 3
1(11.1%)
Phase 2
1(11.1%)
Phase 4
1(11.1%)
9Total
Phase 1(3)
N/A(3)
Phase 3(1)
Phase 2(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials
NCT05491811Phase 2Active Not Recruiting

Ensartinib in Combination With Bevacizumab in ALK-positive NSCLC Patients With TP53 Mutation

Role: collaborator

NCT06343090Not ApplicableRecruiting

Clinical Trial of CD19 and CD22 CAR Sequential Therapy Versus Single CD19 CAR Bridging to HSCT for r/r B-ALL Patients

Role: collaborator

NCT06316856Phase 1Recruiting

CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-cell Malignancies

Role: collaborator

NCT06316427Phase 1Recruiting

Autologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell Malignancies

Role: collaborator

NCT07070323Phase 1Recruiting

A Multicenter, Open-Label, Non-Randomized, Single-Arm Clinical Study of Nanobody CD5-CAR T Cell Therapy for Refractory/Relapsed T Lymphocyte Malignancies

Role: collaborator

NCT07014345Not ApplicableWithdrawn

Double-Lumen Tube Intubation in the Lateral Position Versus the Supine Position on First-Attempt Success Rate

Role: collaborator

NCT06447701Phase 3Not Yet Recruiting

Interleukin-6 Receptor Inhibition for Symptomatic Intracranial Atherosclerosis

Role: collaborator

NCT06763666Phase 4Not Yet Recruiting

CLAG+VEN vs CLAG in the Treatment of Relapsed/Refractory AML

Role: collaborator

NCT06622343Completed

Predictive Modeling of Necrotizing Skin Infections in Snakebite Patients

Role: collaborator

NCT03815448Not ApplicableCompleted

Methotrexate in the Treatment of Advanced Knee Osteoarthritis With Effusion-synovitis

Role: collaborator

NCT01946919Completed

Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study

Role: collaborator

All 11 trials loaded